Drug company Actavis recently made a bid for Allergan, but the Botox maker rejected the proposal and is closing in on its own takeover for Salix Pharmaceuticals.
from WSJ.com: US Business http://ift.tt/XYOjN3
via IFTTT
from WSJ.com: US Business http://ift.tt/XYOjN3
via IFTTT
No comments:
Post a Comment